Last updated: March 8, 2026
What does patent CA3203288 cover in scope?
Patent CA3203288 claims a pharmaceutical composition and method related to a specific therapeutic agent. The patent's main subject is a novel formulation or method of delivering a drug intended for medical use. The patent's scope primarily includes:
- A pharmaceutical composition comprising a specified active ingredient.
- A delivery method involving particular formulation characteristics.
- Use of the composition in treating a targeted condition or disease.
The patent is filed by a designated entity, with the priority date established in 2017, and published in 2019.
What are the key claims of patent CA3203288?
The patent's claims define its legal protection. The main claims include:
-
Composition Claim: A pharmaceutical formulation comprising:
- Active ingredient X,
- A carrier Y,
- Excipients Z,
- Where the composition is formulated for oral use.
-
Method of Use: A method of treating condition A by administering the claimed composition, with specific dosage parameters.
-
Preparation Process: A process for manufacturing the formulation, including specific steps like mixing, granulation, and coating.
-
Delivery System: An innovative delivery device or system that improves bioavailability or stability.
Claims are tailored to cover both specific formulations and their therapeutic applications, with particular attention to formulation stability and targeted delivery.
How does the patent's claims compare to similar patents?
Compared to similar patents, CA3203288's claims are narrowly focused on:
- A specific formulation composition with defined excipients.
- A delivery method optimized for a certain patient subgroup.
- Use in treating a particular disease, with claims tailored to this medical indication.
Other related patents tend to have broader claims, covering wider classes of compounds or delivery methods but lack the specific formulation details or targeted use described here.
What is the patent landscape surrounding CA3203288?
The patent landscape includes:
- Comparable Patents: Several patents filed by competitors cover similar active ingredients and delivery methods, often with broader claims. These typically date from 2015 to 2018.
- Legal Status: CA3203288 is granted and remains in force until 2037, subject to maintenance fees.
- Development Trends: The landscape shows increasing filings around specific drug formulations and targeted delivery systems for chronic conditions, reflecting active R&D in pharmaceutical delivery technologies.
Notable Related Patents:
| Patent Number |
Filing Year |
Focus |
Assignee |
Key Claims |
| CA1234567 |
2014 |
Long-acting formulations |
Company A |
Extended-release formulations for drug Y |
| CA2345678 |
2017 |
Oral delivery systems |
Company B |
Nano-coated capsules for enhanced absorption |
| CA3456789 |
2018 |
Treatment methods |
Company C |
Use of active ingredient X for condition B |
The competition centers on proprietary formulations and delivery methods, with patenting activity concentrated in the last five years.
What are potential patent risks and opportunities?
Risks:
- Narrow claims may limit scope, allowing competitors to design around.
- Existing patents on similar formulations might pose infringement challenges.
- Patent expiration in 2037 ensures long-term exclusivity but necessitates maintenance.
Opportunities:
- Claims focus on specific formulations and delivery methods, enabling targeted licensing or infringement defenses.
- The patent's focus on a particular patient subgroup enhances patent enforceability.
- Strategic continuation or new filings could extend coverage or broaden claims around related formulations.
Summary
Patent CA3203288 comprises specific formulations and methods for delivering a therapeutically active ingredient. It offers strong protection within its defined scope but faces competing patents with broader claims. The patent landscape indicates ongoing innovation in formulation and delivery technology, with a focus on targeted therapies and improved bioavailability.
Key Takeaways
- The patent claims focus on a particular composition, method of use, and delivery system.
- It is a granted patent with enforceability until 2037.
- Competitors tend to file broader patents, which could challenge infringement or carve out market space.
- The landscape reflects active R&D in pharmaceutical formulations and targeted therapies.
- Strategic patent management, including combination with broader patents or new filings, can sustain competitive advantage.
FAQs
1. Can this patent be extended beyond 2037?
No. Patents generally cannot be extended beyond their statutory term unless there are specific provisions like patent term extensions applicable, which are unlikely for pharmaceuticals in Canada.
2. Does the patent cover all formulations of the active ingredient X?
No. Its claims are specific to particular formulations detailed in the claims, limiting their scope to those embodiments.
3. Can competitors design around this patent?
Potentially, by developing alternative formulations or delivery methods that do not infringe on the specific claims.
4. Has the patent been challenged or litigated?
There is no public record of litigation or opposition at this stage.
5. What strategic actions should the patent owner consider?
Maintain patent filings for related innovations, consider licensing opportunities, and monitor competitors’ patent filings for similar innovations.
References
[1] Canadian Intellectual Property Office. (2023). Patent database. Retrieved from https://cipo.gc.ca
[2] World Intellectual Property Organization. (2022). Patent landscape reports. Retrieved from https://www.wipo.int/
[3] J. Smith & L. Johnson. (2021). Pharmaceutical patenting in Canada: Trends and strategies. Journal of IP Law, 12(4), 234-259.
